Our study suggested that variants in TBX4 may lead to PAH through insufficient lung morphogenesis by disrupting the TBX4-mediated direct regulation of FGF10 signaling and pulmonary vascular endothelial dysfunction involving PAH-related molecules [71]. This evidence concerns the gene TBX4 and pulmonary arterial hypertension.